Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease

S. Reuter, H. Martin, M. Stassen, R. Buhl, L. Eshkind, C. Taube (Mainz, Germany; Leiden, Netherlands)

Source: Annual Congress 2013 –Murine models of lung immunology
Session: Murine models of lung immunology
Session type: Poster Discussion
Number: 1572
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Reuter, H. Martin, M. Stassen, R. Buhl, L. Eshkind, C. Taube (Mainz, Germany; Leiden, Netherlands). Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease. Eur Respir J 2013; 42: Suppl. 57, 1572

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pim1 kinase affects allergic asthma in a HDM-driven mice model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Investigating the role of BAFF in murine models of allergic asthma
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015


Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014


Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


HMGB1 expression and function in the allergic airway immune response
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

GARP reduces inflammation in a humanized mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015

Allergy and the paediatric lung during development
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=79
Year: 2006

RV-infection modifies DNA-methylation in nasal airway epithelium cell line: Evaluation as a possible asthma trigger
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014

Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013


QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015


Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Investigating airway HMGB1 redox state in health and asthma
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014